Sell 3/11/2016Downgrade
RBC Life Sciences Inc. (RBCL) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index, total return index and solvency index.

Sell 11/13/2014Downgrade
RBC Life Sciences Inc. (RBCL) was downgraded to D+ from C- on 11/13/2014 due to a substantial decline in the growth index and solvency index. EBIT declined 334.94% from $33.2 to -$78, operating cash flow declined 175.7% from $570 to -$431.5, and total revenue declined 4.7% from $7.89M to $7.51M.

Hold 9/22/2014Upgraded
RBC Life Sciences Inc. (RBCL) was upgraded to C- from D+ on 9/22/2014 due to a substantial increase in the growth index, volatility index and total return index. Total revenue increased 38.02% from $5.71M to $7.89M.

Sell 6/23/2014Upgraded
RBC Life Sciences Inc. (RBCL) was upgraded to D+ from D on 6/23/2014 due to an increase in the total return index.

Sell 5/27/2014Downgrade
RBC Life Sciences Inc. (RBCL) was downgraded to D from D+ on 5/27/2014 due to a large decline in the growth index, total return index and solvency index. The quick ratio declined from 0.7 to 0.46, EBIT declined 26.61% from -$670.7 to -$492.2, and total revenue declined 11.37% from $6.45M to $5.71M.